One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab Meeting Abstract
| Authors: | Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; Isbell, J.; Hellmann, M. D.; Rimner, A.; Jones, D.; Chaft, J.; Gomez, D. R. |
| Abstract Title: | One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab |
| Meeting Title: | 62nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 108 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2020 Oct 25-28 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-11-01 |
| Start Page: | e113 |
| Language: | English |
| ACCESSION: | WOS:000582521500252 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2020.07.1239 |
| Notes: | Meeting Abstract : 2251 -- Source: Wos |
